Ann: Bod Achieves Word First in Phase 1 Clinical Trial, page-7

The belong to Joanne our founding CEO if I remember correctly.

She can sell a little to pay for some bills and a holiday which is fine as we all have expenses, but I doubt she will sell the lot as her ultimate aim would be to progress BDA to a significant business or a potential take over target under her tenure. 

With that size of a holding, selling the lot would damage BDAs market reputation and trust. It is better executed via an off market transfer to new strategic holders if someone does want a significant stake in BDA, which I believe BDAs management are working on over the long term.

I doubt Tribecca and our new executive chairman and director would have questioned this during the placement process